PetMed Express Zukünftiges Wachstum

Future Kriterienprüfungen 0/6

PetMed Express wird ein jährliches Gewinn- und Umsatzwachstum von 50.8% bzw. 3.3% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 52.4% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich -2.2% betragen.

Wichtige Informationen

50.8%

Wachstumsrate der Gewinne

52.4%

EPS-Wachstumsrate

Specialty Retail Gewinnwachstum	10.2%
Wachstumsrate der Einnahmen	3.3%
Zukünftige Eigenkapitalrendite	-2.2%
Analystenabdeckung	Low
Zuletzt aktualisiert	17 Jun 2024

Jüngste Aktualisierungen zum künftigen Wachstum

PetMed Express, Inc. (NASDAQ:PETS) Just Reported And Analysts Have Been Cutting Their Estimates

Jun 14

Recent updates

PetMed Express, Inc. (NASDAQ:PETS) Just Reported And Analysts Have Been Cutting Their Estimates

Jun 14

PetMed Express, Inc.'s (NASDAQ:PETS) Intrinsic Value Is Potentially 69% Above Its Share Price

Jun 12

PetMed Express CFO to leave post today, by remain with company over transition period

Aug 02

PetMed Express' (NASDAQ:PETS) Dividend Will Be $0.30

Jul 29

PetMed Express FQ1 2023 Earnings Preview

Jul 24

PetMeds becomes exclusive U.S. fulfillment partner for Vetster, telemedicine platform

Jul 15

Returns On Capital At PetMed Express (NASDAQ:PETS) Paint A Concerning Picture

Jul 04

PetMed Express: 'AutoShip & Save' Program Key Driver Of Growth

May 26

PetMed Express (NASDAQ:PETS) Has Affirmed Its Dividend Of US$0.30

May 13

Silver Ring Value Partners - PetMed Express: Squeezed Out Of Obtaining New Customers

Feb 22

PetMed Express: Avoid For Now

Jan 17

PetMed Express Needs A White Knight

Sep 26

Gewinn- und Umsatzwachstumsprognosen

NasdaqGS:PETS - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (USD Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
3/31/2027	312	-2	N/A	N/A	1
3/31/2026	293	-2	N/A	N/A	2
3/31/2025	281	-5	N/A	N/A	2
3/31/2024	281	-7	0	4	N/A
12/31/2023	277	-3	2	7	N/A
9/30/2023	270	-1	17	22	N/A
6/30/2023	265	1	17	22	N/A
3/31/2023	257	5	23	28	N/A
12/31/2022	259	9	23	27	N/A
9/30/2022	261	13	19	23	N/A
6/30/2022	263	17	23	25	N/A
3/31/2022	272	19	17	18	N/A
12/31/2021	279	22	26	28	N/A
9/30/2021	284	25	24	26	N/A
6/30/2021	292	27	48	51	N/A
3/31/2021	304	24	38	40	N/A
12/31/2020	312	31	37	39	N/A
9/30/2020	306	30	34	37	N/A
6/30/2020	300	28	25	28	N/A
3/31/2020	284	26	37	39	N/A
12/31/2019	274	25	33	35	N/A
9/30/2019	275	26	41	42	N/A
6/30/2019	276	31	23	23	N/A
3/31/2019	283	38	45	45	N/A
12/31/2018	286	41	34	34	N/A
9/30/2018	286	43	39	39	N/A
6/30/2018	282	41	45	46	N/A
3/31/2018	274	37	37	37	N/A
12/31/2017	270	35	N/A	51	N/A
9/30/2017	262	30	N/A	38	N/A
6/30/2017	256	27	N/A	48	N/A
3/31/2017	249	24	N/A	47	N/A
12/31/2016	242	22	N/A	30	N/A
9/30/2016	240	22	N/A	35	N/A
6/30/2016	236	21	N/A	23	N/A
3/31/2016	235	21	N/A	21	N/A
12/31/2015	229	20	N/A	25	N/A
9/30/2015	228	20	N/A	22	N/A
6/30/2015	228	18	N/A	29	N/A
3/31/2015	229	17	N/A	32	N/A
12/31/2014	228	17	N/A	25	N/A
9/30/2014	229	17	N/A	13	N/A
6/30/2014	232	18	N/A	8	N/A
3/31/2014	233	18	N/A	14	N/A
12/31/2013	236	18	N/A	9	N/A
9/30/2013	235	18	N/A	22	N/A
6/30/2013	233	18	N/A	19	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: PETS wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Ertrag vs. Markt: PETS wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Hohe Wachstumserträge: PETS wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Einnahmen vs. Markt: PETSDie Einnahmen des Unternehmens (3.3% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (8.7% pro Jahr).

Hohe Wachstumseinnahmen: PETSDie Einnahmen des Unternehmens (3.3% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: PETS wird voraussichtlich in 3 Jahren unrentabel sein.

PetMed Express Zukünftiges Wachstum

Future Kriterienprüfungen 0/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

PetMed Express, Inc. (NASDAQ:PETS) Just Reported And Analysts Have Been Cutting Their Estimates

Price target decreased by 21% to US$7.75

Price target decreased by 18% to US$15.00

Consensus EPS estimates fall by 31%, revenue upgraded

Consensus EPS estimates fall by 20%

Consensus EPS estimates fall by 48%

Recent updates

PetMed Express, Inc., Annual General Meeting, Aug 08, 2024

PetMed Express, Inc. Announces Appointment of Leah Solivan to Board of Directors

PetMed Express, Inc. (NASDAQ:PETS) Just Reported And Analysts Have Been Cutting Their Estimates

Full year 2024 earnings: EPS misses analyst expectations

New major risk - Revenue and earnings growth

PetMed Express, Inc.'s (NASDAQ:PETS) Intrinsic Value Is Potentially 69% Above Its Share Price

PetMed Express, Inc. Announces Christine Chambers Will Leave the Company in Early August 2024

PetMed Express, Inc. Appoints Carla Dodds as Chief Marketing Officer

PetMed Express, Inc. to Report Q4, 2024 Results on Jun 11, 2024

PetMed Express, Inc. Appoints Justin Mennen to Board of Directors, Effective June 3, 2024

Price target decreased by 21% to US$7.75

PetMed Express, Inc. Announces Executive Changes

PetMed Express Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q

PetMed Express, Inc. announced delayed 10-Q filing

PetMed Express, Inc. announced delayed 10-Q filing

PetMed Express, Inc. to Report Q3, 2024 Results on Feb 08, 2024

PetMed Express, Inc. Announces Management Changes

Independent Chairman of the Board recently bought US$301k worth of stock

CEO, President & Director recently bought US$101k worth of stock

PetMed Express, Inc. Makes Decision to Suspend the Quarterly Dividend Effective the Quarter Ended September 30, 2023

PetMed Express, Inc. to Report Q2, 2024 Results on Oct 30, 2023

Price target decreased by 18% to US$15.00

Now 21% undervalued after recent price drop

A Look At The Fair Value Of PetMed Express, Inc. (NASDAQ:PETS)

PetMed Express (NASDAQ:PETS) Is Paying Out A Dividend Of $0.30

Upcoming dividend of US$0.30 per share at 9.0% yield

First quarter 2024 earnings: EPS and revenues miss analyst expectations

PetMed Express, Inc. to Report Q1, 2024 Results on Jul 31, 2023

Now 21% undervalued after recent price drop

High number of new directors

Consensus EPS estimates fall by 31%, revenue upgraded

Upcoming dividend of US$0.30 per share at 8.1% yield

Full year 2023 earnings: EPS and revenues miss analyst expectations

PetMed Express, Inc. Declares a Quarterly Dividend, Payable on June 12, 2023

PetMed Express, Inc., Annual General Meeting, Aug 03, 2023

Now 22% undervalued after recent price drop

PetMed Express, Inc. Appoints Sandra Y. Campos to its Board of Directors

PetMed Express, Inc. to Report Q4, 2023 Results on May 22, 2023

Consensus EPS estimates fall by 20%

The Returns On Capital At PetMed Express (NASDAQ:PETS) Don't Inspire Confidence

Consensus EPS estimates fall by 48%

PetMed Express (NASDAQ:PETS) Will Pay A Dividend Of $0.30

Third quarter 2023 earnings released: US$0.001 loss per share (vs US$0.21 profit in 3Q 2022)

PetMed Express, Inc. Declares Quarterly Dividend, Payable on February 27, 2023

Investor sentiment improves as stock rises 16%

PetMed Express, Inc. to Report Q3, 2023 Results on Feb 06, 2023

PetMed Express, Inc. entered into an agreement to acquire PetCareRx, Inc. from Evolution VC Partners and Feenix Venture Partners.

PetMed Express, Inc. entered into an agreement to acquire PetCareRx, Inc. from Evolution VC Partners and Feenix Venture Partners.

PetMed Express (NASDAQ:PETS) Will Pay A Dividend Of $0.30

Price target decreased to US$20.67

PetMed Express, Inc. Declares Quarterly Dividend, Payable on November 30, 2022

Price target decreased to US$21.33

PetMed Express, Inc. to Report Q2, 2023 Results on Nov 07, 2022

PetMed Express Puts Are Compelling

Now 21% undervalued after recent price drop

Upcoming dividend of US$0.30 per share

Now 23% undervalued after recent price drop

PetMed Express CFO to leave post today, by remain with company over transition period

Consensus EPS estimates fall by 15%

PetMed Express' (NASDAQ:PETS) Dividend Will Be $0.30

First quarter 2023 earnings: EPS and revenues miss analyst expectations

Petmed Express, Inc. Declares Quarterly Dividend, Payable on August 19, 2022

PetMed Express FQ1 2023 Earnings Preview

PetMed Express, Inc. Announces Executive Changes

PetMeds becomes exclusive U.S. fulfillment partner for Vetster, telemedicine platform

PetMed Express, Inc. to Report Q1, 2023 Results on Jul 25, 2022

Price target decreased to US$23.33

Returns On Capital At PetMed Express (NASDAQ:PETS) Paint A Concerning Picture

PetMed Express, Inc., Annual General Meeting, Jul 28, 2022